Using a Population Pharmacokinetic Model to Estimate the Dosage of Teicoplanin in Patients With Hematologic Malignancy or Critical Illness
Not yet recruitingOBSERVATIONAL
Enrollment
600
Participants
Timeline
Start Date
January 1, 2025
Primary Completion Date
September 30, 2025
Study Completion Date
December 31, 2025
Conditions
Hematological MalignanciesCritical Illness
Interventions
OTHER
concentration of teicoplanin
post analysis of concentration of teicoplanin
All Listed Sponsors
lead
National Taiwan University Hospital
OTHER
NCT06674330 - Using a Population Pharmacokinetic Model to Estimate the Dosage of Teicoplanin in Patients With Hematologic Malignancy or Critical Illness | Biotech Hunter | Biotech Hunter